Norethisterone
| Evidence Level: N/A | Predicted Indications: 0 |
Table of Contents
Norethisterone
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not recorded in the local data |
| India Market Status | Listed in a compiled Indian medicine price dataset (at least 20) – CDSCO approval status is not included in this data |
| Number of Listed Products | at least 20 |
India Market Information
| Authorization Number | Product Name | Dosage Form | Approved Indication |
|---|---|---|---|
| Registration No. 78840 | Esnorisa 10 CR Tablet | Strip of 10 CR tablets | Not stated |
| Registration No. 101061 | Gestodian 5mg Tablet | Strip of 10 tablets | Not stated |
| Registration No. 133984 | Mendate 10 Tablet CR | Strip of 10 CR tablets | Not stated |
| Registration No. 156418 | Noriden 5mg Tablet | Strip of 10 tablets | Not stated |
| Registration No. 187703 | Rethrowel CR 10mg Tablet | Strip of 10 tablets | Not stated |
All 20 registrations are valid single-ingredient oral products.
Safety Considerations
- Contraindications (from the knowledge graph, not label text): hypertension, epilepsy, anxiety and neurotic disorders, porphyria, kidney disease, liver disease, gallbladder disease, diabetes mellitus and hyperglycaemia, hypertriglyceridaemia, hypercalcaemia, hypothyroidism, systemic lupus erythematosus, asthma, and female breast carcinoma.
- Drug Interactions: 159 interactions were identified. The ones listed here are all moderate and mostly involve antidiabetic agents (acarbose, metformin, dapagliflozin, linagliptin, insulin products, GLP-1 agonists such as exenatide, dulaglutide, lixisenatide and albiglutide), plus aprepitant, clotrimazole, metreleptin, and prucalopride.
Package insert warnings were not available; please refer to the package insert for full safety information.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.